As of 2025-05-18, the Relative Valuation of Reviv3 Procare Co (RVIV) is 6.55 USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.76 USD, the upside of Reviv3 Procare Co based on Relative Valuation is -48.7%.
The range of the Relative Valuation is 5.28 - 7.82 USD.
| Range | Selected | |
| Trailing P/E multiples | 12.8x - 18.8x | 15.8x |
| Forward P/E multiples | 11.9x - 17.6x | 14.8x |
| Fair Price | 5.28 - 7.82 | 6.55 |
| Upside | -58.6% - -38.7% | -48.7% |
| Date | P/E |